Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity
Spinal muscular atrophy is a genetic neuromuscular disease characterised by muscle atrophy, hypotonia, weakness, and progressive paralysis. Usually, these patients display increased fat mass deposition and reductions in fat-free mass and resting energy expenditure—an unfavourable condition that faci...
Saved in:
Main Authors: | Marwan El Ghoch, Paola Vittoria Bazzani, Simona Calugi, Riccardo Dalle Grave |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/4058429 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resting Energy Expenditure in Anorexia Nervosa: Measured versus Estimated
by: Marwan El Ghoch, et al.
Published: (2012-01-01) -
Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
by: Fumiaki Tanaka, et al.
Published: (2012-01-01) -
Unraveling the genetic mysteries of spinal muscular atrophy in Chinese families
by: Shanshan Gao, et al.
Published: (2025-01-01) -
Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy
by: Hooi Ling Teoh, et al.
Published: (2017-01-01) -
Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular Atrophy
by: Hiangkiat Tan, et al.
Published: (2019-12-01)